Miltefosine
Overview
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Perindopril's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 1.5 to 2.5 mg/kg/day | 2 (2) | As recommended. | PO | Should be given for 28 days.The dose should be adjusted based on patients weight so that a dose of 4mg/kg per day is not exceeded. |
| 6 % | 6 (6) | As recommended. | Topical | Once or twice daily for skin metastasis. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Perindopril is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Plasma Protein Fraction is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Plasma Protein Fraction
Back to top
Previous Drug Generic - Next Drug Generic